{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:04:36Z","timestamp":1773176676991,"version":"3.50.1"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2011,4,27]],"date-time":"2011-04-27T00:00:00Z","timestamp":1303862400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0019333","type":"journal-article","created":{"date-parts":[[2011,4,27]],"date-time":"2011-04-27T20:54:07Z","timestamp":1303937647000},"page":"e19333","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["The Combination of Homocysteine and C-Reactive Protein Predicts the Outcomes of Chinese Patients with Parkinson's Disease and Vascular Parkinsonism"],"prefix":"10.1371","volume":"6","author":[{"given":"Limin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cansheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianfang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,4,27]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson&apos;s disease.","volume":"167","author":"H Chen","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/jnnp.2008.162883","article-title":"Association of the human leucocyte antigen region with susceptibility to Parkinson&apos;s disease.","volume":"81","author":"M Saiki","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.freeradbiomed.2009.11.026","article-title":"Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.","volume":"48","author":"RC Seet","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1002\/mds.22638","article-title":"Inflammation and Parkinson&apos;s disease pathogenesis.","volume":"25","author":"S Przedborski","year":"2010","journal-title":"Mov Disord"},{"key":"ref5","article-title":"Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson&apos;s disease.","author":"IU Song","year":"2010"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000222780","article-title":"Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson&apos;s disease? A comparison of Parkinson&apos;s disease patients, disease controls and healthy individuals.","volume":"62","author":"IU Song","year":"2009","journal-title":"Eur Neurol"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/mds.22522","article-title":"Homocysteine and cognitive impairment in Parkinson&apos;s disease: a biochemical, neuroimaging, and genetic study.","volume":"24","author":"MC Rodriguez-Oroz","year":"2009","journal-title":"Mov Disord"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/mds.22511","article-title":"Hyperhomocysteinemia in levodopa-treated patients with Parkinson&apos;s disease dementia.","volume":"24","author":"S Zoccolella","year":"2009","journal-title":"Mov Disord"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/mds.22607","article-title":"Homocysteine levels after acute levodopa intake in patients with Parkinson&apos;s disease.","volume":"24","author":"T M\u00fcller","year":"2009","journal-title":"Mov Disord"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/mds.22482","article-title":"Cysteine elevation in levodopa-treated patients with Parkinson&apos;s disease.","volume":"24","author":"T M\u00fcller","year":"2009","journal-title":"Mov Disord"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/092986710790149774","article-title":"Elevated homocysteine levels in Parkinson&apos;s Disease: is there anything besides L-dopa treatment?","volume":"17","author":"S Zoccolella","year":"2010","journal-title":"Curr Med Chem"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mds.22227","article-title":"Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson&apos;s disease patients.","volume":"24","author":"RM Camicioli","year":"2009","journal-title":"Mov Disord"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1001\/archneur.64.11.1646","article-title":"Mild parkinsonian signs and plasma homocysteine concentration in community-dwelling elderly individuals.","volume":"64","author":"ED Louis","year":"2007","journal-title":"Arch Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrneurol.2009.156","article-title":"Parkinson disease. Nonmotor symptoms in Parkinson disease: the PRIAMO study.","volume":"5","author":"RF Pfeiffer","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"ref15","article-title":"Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson&apos;s disease.","author":"H Li","year":"2010","journal-title":"Mov Disord"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson&apos;s: a clinico-pathological study of 100 cases.","volume":"55","author":"AJ Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.","volume":"19","author":"JC Zijlmans","year":"2004","journal-title":"Mov Disord"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.parkreldis.2009.07.003","article-title":"Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson&apos;s disease patients.","volume":"16","author":"N Klepac","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"ref19","first-page":"189","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000165343","article-title":"Vascular parkinsonism: a clinical review.","volume":"61","author":"HT Benamer","year":"2009","journal-title":"Eur Neurol"},{"key":"ref21","article-title":"The unified Parkison disease rating scale. Macmillan Health Care Information.","author":"S Fahn","year":"1987","journal-title":"Recent developments in Parkinson's disease"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality.","volume":"17","author":"MM Hoehn","year":"1967","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson&apos;s disease: Results from an international pilot study.","volume":"22","author":"KR Chaudhuri","year":"2007","journal-title":"Mov Disord"},{"issue":"7","key":"ref24","first-page":"677","article-title":"Higher C-reactive protein concentration and white blood cell count in subjects with more coronary risk factors and\/or lower physical fitness among apparently healthy Japanese Circ J","volume":"66","author":"Y Ichihara","year":"2002"},{"key":"ref25","article-title":"Correlation and regression Statistics at square one, 9th ed University of Southampton: BMJ Publishing Group","author":"D Swinscow","year":"1997"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mds.22937","article-title":"Differentiating vascular parkinsonism from idiopathic Parkinson&apos;s disease: a systematic review.","volume":"25","author":"S Kalra","year":"2010","journal-title":"Mov Disord"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archneur.56.1.98","article-title":"Clinical correlates of vascular parkinsonism.","volume":"56","author":"J Winikates","year":"1999","journal-title":"Arch Neurol"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/mds.21479","article-title":"[123I] FP-CIT spect study in vascular parkinsonism and Parkinson&apos;s disease.","volume":"22","author":"J Zijlmans","year":"2007","journal-title":"Mov Disord"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/52.1.23","article-title":"Arteriosclerotic parkinsonism.","volume":"52","author":"M Critchley","year":"1929","journal-title":"Brain"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/01.WNL.0000032494.05619.93","article-title":"Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study.","volume":"59","author":"ND Prins","year":"2002","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer&apos;s disease.","volume":"346","author":"S Seshadri","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ana.22220","article-title":"Elevated plasma YKL-40 levels and ischemic stroke in the general population.","volume":"68","author":"AD Kjaergaard","year":"2010","journal-title":"Ann Neurol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.60.1.59","article-title":"Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease.","volume":"60","author":"JD Rogers","year":"2003","journal-title":"Arch Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1212\/WNL.45.12.2183","article-title":"MRI in patients with suspected vascular parkinsonism.","volume":"45","author":"JC Zijlmans","year":"1995","journal-title":"Neurology"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/jnnp.2003.018309","article-title":"The L-dopa response in vascular parkinsonism.","volume":"75","author":"JC Zijlmans","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.parkreldis.2008.05.014","article-title":"Serum inflammatory biomarkers in Parkinson&apos;s disease.","volume":"15","author":"M Dufek","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.61.6.865","article-title":"Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations.","volume":"61","author":"PE O'Suilleabhain","year":"2004","journal-title":"Arch Neurol"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mds.20261","article-title":"Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson&apos;s disease patients.","volume":"20","author":"P Lamberti","year":"2005","journal-title":"Mov Disord"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1468-1331.2004.00973.x","article-title":"Hyperhomocysteinemia in L-dopa treated Parkinson&apos;s disease patients: effect of cobalamin and folate administration.","volume":"12","author":"P Lamberti","year":"2005","journal-title":"Eur J Neurol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/mds.21997","article-title":"Rivastigmine versus placebo in hyperhomocysteinemic Parkinson&apos;s disease dementia patients.","volume":"23","author":"P Barone","year":"2008","journal-title":"Mov Disord"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0019333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T09:51:37Z","timestamp":1540288297000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0019333"}},"subtitle":[],"editor":[{"given":"Joe Z.","family":"Tsien","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,27]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0019333","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,27]]}}}